RSSS•October 6, 2026 at 12:00 PM UTCSoftware & Services

Research Solutions' Scite Partners with MDPI to Index Open Access Journals for AI Discovery

Read source article

What happened

Research Solutions announced a collaboration with MDPI, the open access publisher, to index MDPI's journal portfolio in Scite and make it available via the Scite MCP for AI environments like ChatGPT and Claude. This expands the content available for Scite's smart citation and AI-assisted research tools, potentially enhancing its value proposition for users. However, the financial terms were not disclosed, and given that MDPI content is already open access, the incremental value may be limited to improved discoverability and integration rather than exclusive content. The partnership is likely non-exclusive, so Scite gains no structural moat from this deal. While it supports the narrative of AI adoption in research, it does not address key risks such as earnout obligations, publisher concentration, or competition from larger AI platforms.

Implication

The partnership reinforces Scite's positioning as a comprehensive AI-powered research tool, potentially aiding customer acquisition and usage. However, because MDPI content is already openly accessible, the incremental value may be limited to improved discoverability and smart citations. The deal is likely non-exclusive and does not address structural risks such as publisher concentration, contingent earnouts, or competition from better-funded AI rivals. Investors should watch whether this partnership translates into increased ARR growth or platform adoption in the coming quarters. Until such evidence emerges, the partnership alone should not justify a change in the cautious, thesis-driven stance outlined in the master report.

Thesis delta

This announcement does not materially alter the investment thesis. It provides incremental validation of Scite's AI utility but does not change the core drivers of ARR growth, margin expansion, or the risks around earnouts and competition. The thesis remains a potential buy based on valuation and execution, with no upgrade warranted solely from this partnership.

Confidence

Moderate